Spermosens AB (publ) (NGM:SPERM)
Sweden · Delayed Price · Currency is SEK 0.0084
+0.0002 (2.44%)
At close: Sep 30, 2026
Spermosens AB Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
26.65M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 38.00K | 31.00K | 442.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thinc Collective AB | 321.00M |
| Sarsys AB | 53.75M |
| Jumpgate AB | 42.69M |
| Diadrom Holding AB | 37.88M |
| ODI Pharma AB | 32.92M |
| Kvix AB | 14.84M |
| LightAir AB | 12.08M |
| Holdflight AB | 10.11M |
Spermosens AB News
- 7 weeks ago - Spermosens AB Transcript: Status update - Transcripts
- 2 months ago - Spermosens AB Quarterly report: Q2 2026 - Filings
- 5 months ago - Spermosens AB Quarterly report: Q1 2026 - Filings
- 6 months ago - Spermosens AB Transcript: Status update - Transcripts
- 8 months ago - Spermosens AB Quarterly report: Q4 2025 - Filings
- 8 months ago - Spermosens AB Annual report: Q4 2025 - Filings
- 11 months ago - Spermosens AB Quarterly report: Q3 2025 - Filings